BioCardia - Warrants (26/07/2022) Accounts Payable

As of the most recent data (March 2026), BCDAW shows a accounts payable of $820K. That compares with $820K in the prior-year period — up 0.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCDAW's accounts payable is now $820K (was $820K) — a 0.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioCardia - Warrants (26/07/2022) is outperforming or lagging.

Tracking BCDAW's accounts payable over time shows whether BioCardia - Warrants (26/07/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $820K That compares with $820K in the prior-year period — up 0.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has BioCardia - Warrants (26/07/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $820K) with ownership activity and broader fundamentals.

BioCardia - Warrants (26/07/2022)'s accounts payable is $820K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.